Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD

Respiratory Medicine

Volumn 107, Issue 5, 2013, Pages 708-716

  Guenette, Jordan A ^a,b,c   Webb, Katherine A ^a   O'Donnell, Denis E ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Cycle endurance; Exercise; Respiratory physiology; Work of breathing

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; PLACEBO;

ADULT; AGED; ARTICLE; BREATHING MECHANICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; EXPLORATORY RESEARCH; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; INSPIRATORY CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; TIDAL VOLUME;

ADMINISTRATION, INHALATION; ADULT; AGED; ALBUTEROL; ANDROSTADIENES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DYSPNEA; EXERCISE; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MECHANICS; TREATMENT OUTCOME;

EID: 84876060582     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.01.009     Document Type: Article

References (46)

1. J.E. McDonough, R. Yuan, M. Suzuki, N. Seyednejad, W.M. Elliott, and P.G. Sanchez Small-airway obstruction and emphysema in chronic obstructive pulmonary disease N Engl J Med 365 2011 1567 1575
2. J.C. Hogg, F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, and L. Buzatu The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 2004 2645 2653
3. J.A. Barbera, A. Riverola, J. Roca, J. Ramirez, P.D. Wagner, and D. Ros Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease Am J Respir Crit Care Med 149 1994 423 429
4. R. Rodriguez-Roisin, M. Drakulovic, D.A. Rodriguez, J. Roca, J.A. Barbera, and P.D. Wagner Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity J Appl Physiol 106 2009 1902 1908
5. 1 in smokers using quantitative computed tomography Thorax 64 2009 944 949
6. A.F. Gelb, J.C. Hogg, N.L. Muller, M.J. Schein, J. Kuei, and D.P. Tashkin Contribution of emphysema and small airways in COPD Chest 109 1996 353 359
7. K. Kuwano, K. Matsuba, T. Ikeda, J. Murakami, A. Araki, and H. Nishitani The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores Am Rev Respir Dis 141 1990 169 178
8. A.S. Buist, and B.B. Ross Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction Am Rev Respir Dis 108 1973 1078 1087
9. A. Deesomchok, K.A. Webb, L. Forkert, Y.M. Lam, D. Ofir, and D. Jensen Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity COPD 7 2010 428 437
10. P.W. Jones, G. Brusselle, R.W. Dal Negro, M. Ferrer, P. Kardos, and M.L. Levy Properties of the COPD assessment test in a cross-sectional European study Eur Respir J 38 2011 29 35
11. M. Ferrer, J. Alonso, J. Morera, R.M. Marrades, A. Khalaf, and M.C. Aguar Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group Ann Intern Med 127 1997 1072 1079
12. D. Ofir, P. Laveneziana, K.A. Webb, Y.M. Lam, and D.E. O'Donnell Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease Am J Respir Crit Care Med 177 2008 622 629
13. T. Troosters, F. Sciurba, S. Battaglia, D. Langer, S.R. Valluri, and L. Martino Physical inactivity in patients with COPD, a controlled multi-center pilot-study Respir Med 104 2010 1005 1011
14. J.A. Guenette, D. Jensen, K.A. Webb, D. Ofir, N. Raghavan, and D.E. O'Donnell Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms Respir Physiol Neurobiol 177 2011 218 227
15. D.E. O'Donnell, P. Laveneziana, J. Ora, K.A. Webb, Y.M. Lam, and D. Ofir Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD Thorax 64 2009 216 223
16. The Lung Health Research Group Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease N Engl J Med 343 2000 1902 1909
17. P. Calverley, R. Pauwels, J. Vestbo, P. Jones, N. Pride, and A. Gulsvik Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial Lancet 361 2003 449 456
18. N.A. Hanania, P. Darken, D. Horstman, C. Reisner, B. Lee, and S. Davis The efficacy and safety of fluticasone propionate (250 μg)/salmeterol (50 μg) combined in the Diskus inhaler for the treatment of COPD Chest 124 2003 834 843
19. D.A. Mahler, P. Wire, D. Horstman, C.N. Chang, J. Yates, and T. Fischer Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 1084 1091
20. H. Worth, K. Forster, G. Eriksson, U. Nihlen, S. Peterson, and H. Magnussen Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD Respir Med 104 2010 1450 1459
21. D.E. O'Donnell, F. Sciurba, B. Celli, D.A. Mahler, K.A. Webb, and C.J. Kalberg Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD Chest 130 2006 647 656
22. J.A. Guenette, N. Raghavan, V. Harris-McAllister, M.E. Preston, K.A. Webb, and D.E. O'Donnell Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD Respir Med 105 2011 1836 1845
23. A. Wanner, G. Horvath, J.L. Brieva, S.D. Kumar, and E.S. Mendes Nongenomic actions of glucocorticosteroids on the airway vasculature in asthma Proc Am Thorac Soc 1 2004 235 238
24. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, and P. Calverley Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
25. D.A. Mahler, and T.J. Witek Jr. The MCID of the transition dyspnea index is a total score of one unit COPD 2 2005 99 103
26. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, and A. Coates Standardisation of spirometry Eur Respir J 26 2005 319 338
27. J. Wanger, J.L. Clausen, A. Coates, O.F. Pedersen, V. Brusasco, and F. Burgos Standardisation of the measurement of lung volumes Eur Respir J 26 2005 511 522
28. N. MacIntyre, R.O. Crapo, G. Viegi, D.C. Johnson, C.P. van der Grinten, and V. Brusasco Standardisation of the single-breath determination of carbon monoxide uptake in the lung Eur Respir J 26 2005 720 735
29. American Thoracic Society and European Respiratory Society ATS/ERS statement on respiratory muscle testing Am J Respir Crit Care Med 166 2002 518 624
30. E. Oostveen, D. MacLeod, H. Lorino, R. Farre, Z. Hantos, and K. Desager The forced oscillation technique in clinical practice: methodology, recommendations and future developments Eur Respir J 22 2003 1026 1041
31. A.S. Buist Early detection of airways obstruction by the closing volume technique Chest 64 1973 495 499
32. J.F. Morris, A. Koski, W.P. Temple, A. Claremont, and D.R. Thomas Fifteen-year interval spirometric evaluation of the Oregon predictive equations Chest 93 1988 123 127
33. R.O. Crapo, A.H. Morris, P.D. Clayton, and C.R. Nixon Lung volumes in healthy nonsmoking adults Bull Eur Physiopathol Respir 18 1982 419 425
34. B. Burrows, J.E. Kasik, A.H. Niden, and W.R. Barclay Clinical usefulness of the single-breath pulmonary diffusing capacity test Am Rev Respir Dis 84 1961 789 806
35. W.A. Briscoe, and A.B. Dubois The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size J Clin Invest 37 1958 1279 1285
36. A.S. Buist, and B.B. Ross Predicted values for closing volumes using a modified single breath nitrogen test Am Rev Respir Dis 107 1973 744 752
37. G.A. Borg Psychophysical bases of perceived exertion Med Sci Sports Exerc 14 1982 377 381
38. P.M. Simon, R.M. Schwartzstein, J.W. Weiss, V. Fencl, M. Teghtsoonian, and S.E. Weinberger Distinguishable types of dyspnea in patients with shortness of breath Am Rev Respir Dis 142 1990 1009 1014
39. D.E. O'Donnell, A.L. Hamilton, and K.A. Webb Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD J Appl Physiol 101 2006 1025 1035
40. C.M. Laroche, A.K. Mier, J. Moxham, and M. Green The value of sniff esophageal pressures in the assessment of global inspiratory muscle strength Am Rev Respir Dis 138 1988 598 603
41. B. Jones, and M.G. Kenward Design and analysis of cross-over trials 1989 Chapman and Hall London
42. J.L. Hankinson, J.R. Odencrantz, and K.B. Fedan Spirometric reference values from a sample of the general U.S. population Am J Respir Crit Care Med 159 1999 179 187
43. D.E. O'Donnell, N. Voduc, M. Fitzpatrick, and K.A. Webb Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Eur Respir J 24 2004 86 94
44. D.E. O'Donnell, S.M. Revill, and K.A. Webb Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 770 777
45. M.M. Peters, K.A. Webb, and D.E. O'Donnell Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD Thorax 61 2006 559 567
46. D.E. O'Donnell, A. Deesomchok, Y.M. Lam, J.A. Guenette, N. Amornputtisathaporn, and L. Forkert Effects of BMI on static lung volumes in patients with airway obstruction Chest 140 2011 461 468